Article
Neuroprotection in early stages of Alzheimer’s Disease is promoted by Transthyretin…
bioRxiv · 2021 · Tiago Gião
Key facts
| Title | Neuroprotection in early stages of Alzheimer’s Disease is promoted by Transthyretin angiogenic properties |
|---|---|
| First author | Tiago Gião |
| Journal | bioRxiv |
| Published | Apr 16, 2021 |
| DOI | 10.1101/2021.04.16.440131 |
| Devices mentioned | 022122, K800552, K853723, K860811, K862004, K874160, K874609, K912581, K912666, K915561, K915840, K920529 and 12 more |
| Product codes mentioned | EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, KKX, LIQ |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1